Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Vorinostat Plus Tacrolimus & Mycophenolate to Prevent Graft Versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant

NCT00810602 is registered in ClinicalTrials.gov with Pavan Reddy, MD as lead sponsor.

NCT NCT00810602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00810602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Vorinostat Plus Tacrolimus & Mycophenolate to Prevent Graft Versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant
Lead sponsor
Pavan Reddy, MD
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2009
Completion date
July 31, 2013
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graft vs host disease, hematologic malignancies